fialuridine has been researched along with Adenocarcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heo, K; Kang, SH; Kim, D; Kim, EO; Kim, H; Kim, IH; Kim, KT; Kim, SK; Kim, YH; Koh, SS; Lee, SJ; Lee, SW; Lee, Y; Moon, JY; Song, MS | 1 |
Blasberg, R; Burgman, P; Cai, S; Finn, R; Gelovani, J; Li, GC; Ling, CC; O'donoghue, J; Serganova, I; Wen, B; Zanzonico, P | 1 |
2 other study(ies) available for fialuridine and Adenocarcinoma
Article | Year |
---|---|
Efficient targeting and tumor retardation effect of pancreatic adenocarcinoma up-regulated factor (PAUF)-specific RNA replacement in pancreatic cancer mouse model.
Topics: Adenocarcinoma; Adenoviridae; Animals; Arabinofuranosyluracil; Cell Line, Tumor; Female; Genetic Therapy; Humans; Intercellular Signaling Peptides and Proteins; Iodine Radioisotopes; Lectins; Mice; Mice, Inbred BALB C; Pancreatic Neoplasms; Random Allocation; RNA; RNA, Catalytic; Thymidine Kinase; Tomography, Emission-Computed, Single-Photon; Transgenes; Xenograft Model Antitumor Assays | 2014 |
A preclinical model for noninvasive imaging of hypoxia-induced gene expression; comparison with an exogenous marker of tumor hypoxia.
Topics: Adenocarcinoma; Animals; Arabinofuranosyluracil; Biomarkers, Tumor; Cell Hypoxia; Cell Line, Tumor; Disease Models, Animal; DNA-Binding Proteins; Drug Evaluation, Preclinical; Feasibility Studies; Fluorine Radioisotopes; Gene Expression Profiling; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Iodine Radioisotopes; Misonidazole; Nuclear Proteins; Radionuclide Imaging; Radiopharmaceuticals; Rats; Thymidine Kinase; Transcription Factors; Viral Proteins | 2004 |